Aadi Bioscience (NASDAQ: AADI) has announced that it will be releasing its financial results for the third quarter of 2024 on Wednesday 6th November 2024. The report will be made available before market open, allowing investors and analysts to evaluate the company's performance during this period.
According to the predictions of financial experts on Wall Street, the organization is set to unveil an estimated $0.46 loss per share for the quarter. Additionally, the company is expected to report a total revenue of $6.6 million for the specific period.
According to the Wall Street analysts projections, the company is expected to generate a total revenue of $25.02 million for the fiscal year. Additionally, these analysts anticipate that the company will report loss of $2.02 per share during the same period.
The earnings report for the corresponding quarter in the previous year showcased a per-share loss of $0.6. This considerable sum was attributed to the company's total revenue, which reached an impressive $5.96 million during that specific quarter.
Aadi Bioscience (AADI) shares traded as low as $1.97 and as high as $2.01 on a day volume of 25.00 thousand shares, closed Friday's regular trading session at $1.99, of 0.00 percent.
